0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Posterior Pituitary for Injection Market Research Report 2024
Published Date: December 2024
|
Report Code: QYRE-Auto-31K18530
Home | Market Reports | Health| Reproductive Health
Global Posterior Pituitary for Injection Market Research Report 2024
BUY CHAPTERS

Global Posterior Pituitary for Injection Market Research Report 2024

Code: QYRE-Auto-31K18530
Report
December 2024
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Posterior Pituitary for Injection Market Size

The global market for Posterior Pituitary for Injection was valued at US$ 235 million in the year 2023 and is projected to reach a revised size of US$ 328 million by 2030, growing at a CAGR of 5.6% during the forecast period.

Posterior Pituitary for Injection Market

Posterior Pituitary for Injection Market

Posterior pituitary injection is a drug containing natural or synthetic posterior pituitary hormones (mainly oxytocin and vasopressin). It is mainly used in medical emergency and specific clinical situations to induce and strengthen uterine contractions. It is often used to induce labor during delivery and control postpartum hemorrhage. Oxytocin can promote the contraction of uterine smooth muscle, help speed up the delivery process, and reduce the risk of postpartum hemorrhage.
North American market for Posterior Pituitary for Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Posterior Pituitary for Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Posterior Pituitary for Injection include Eisai (Liaoning) Pharmaceutical, Shanghai No. 1 Biochemical & Pharmaceutical, Nanjing Xinbai Pharmaceutical, Anhui Hongye Pharmaceutical, Kamp Pharmaceutical, Chengdu Hepatunn Pharmaceutical, Beijing Science Sun, Shanghai Harvest Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Posterior Pituitary for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Posterior Pituitary for Injection.
The Posterior Pituitary for Injection market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Posterior Pituitary for Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Posterior Pituitary for Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Posterior Pituitary for Injection Market Report

Report Metric Details
Report Name Posterior Pituitary for Injection Market
Accounted market size in year US$ 235 million
Forecasted market size in 2030 US$ 328 million
CAGR 5.6%
Base Year year
Forecasted years 2024 - 2030
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Eisai (Liaoning) Pharmaceutical, Shanghai No. 1 Biochemical & Pharmaceutical, Nanjing Xinbai Pharmaceutical, Anhui Hongye Pharmaceutical, Kamp Pharmaceutical, Chengdu Hepatunn Pharmaceutical, Beijing Science Sun, Shanghai Harvest Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Posterior Pituitary for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Posterior Pituitary for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Posterior Pituitary for Injection Market growing?

Ans: The Posterior Pituitary for Injection Market witnessing a CAGR of 5.6% during the forecast period 2024-2030.

What is the Posterior Pituitary for Injection Market size in 2030?

Ans: The Posterior Pituitary for Injection Market size in 2030 will be US$ 328 million.

Who are the main players in the Posterior Pituitary for Injection Market report?

Ans: The main players in the Posterior Pituitary for Injection Market are Eisai (Liaoning) Pharmaceutical, Shanghai No. 1 Biochemical & Pharmaceutical, Nanjing Xinbai Pharmaceutical, Anhui Hongye Pharmaceutical, Kamp Pharmaceutical, Chengdu Hepatunn Pharmaceutical, Beijing Science Sun, Shanghai Harvest Pharmaceutical

What are the Application segmentation covered in the Posterior Pituitary for Injection Market report?

Ans: The Applications covered in the Posterior Pituitary for Injection Market report are Lung or Bronchi Bleeding, Gastrointestinal Bleeding, Obstetric Oxytocia, Others

What are the Type segmentation covered in the Posterior Pituitary for Injection Market report?

Ans: The Types covered in the Posterior Pituitary for Injection Market report are Intramuscular Injection, Intravenous Drip

Recommended Reports

Hormonal Therapies

Reproductive Health

Critical Care Agents

1 Posterior Pituitary for Injection Market Overview
1.1 Product Definition
1.2 Posterior Pituitary for Injection by Type
1.2.1 Global Posterior Pituitary for Injection Market Value Comparison by Type (2024-2030)
1.2.2 Intramuscular Injection
1.2.3 Intravenous Drip
1.3 Posterior Pituitary for Injection by Application
1.3.1 Global Posterior Pituitary for Injection Market Value by Application (2024-2030)
1.3.2 Lung or Bronchi Bleeding
1.3.3 Gastrointestinal Bleeding
1.3.4 Obstetric Oxytocia
1.3.5 Others
1.4 Global Posterior Pituitary for Injection Market Size Estimates and Forecasts
1.4.1 Global Posterior Pituitary for Injection Revenue 2019-2030
1.4.2 Global Posterior Pituitary for Injection Sales 2019-2030
1.4.3 Global Posterior Pituitary for Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Posterior Pituitary for Injection Market Competition by Manufacturers
2.1 Global Posterior Pituitary for Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Posterior Pituitary for Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Posterior Pituitary for Injection Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Posterior Pituitary for Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Posterior Pituitary for Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Posterior Pituitary for Injection, Product Type & Application
2.7 Global Key Manufacturers of Posterior Pituitary for Injection, Date of Enter into This Industry
2.8 Global Posterior Pituitary for Injection Market Competitive Situation and Trends
2.8.1 Global Posterior Pituitary for Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Posterior Pituitary for Injection Players Market Share by Revenue
2.8.3 Global Posterior Pituitary for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Posterior Pituitary for Injection Market Scenario by Region
3.1 Global Posterior Pituitary for Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Posterior Pituitary for Injection Sales by Region: 2019-2030
3.2.1 Global Posterior Pituitary for Injection Sales by Region: 2019-2024
3.2.2 Global Posterior Pituitary for Injection Sales by Region: 2025-2030
3.3 Global Posterior Pituitary for Injection Revenue by Region: 2019-2030
3.3.1 Global Posterior Pituitary for Injection Revenue by Region: 2019-2024
3.3.2 Global Posterior Pituitary for Injection Revenue by Region: 2025-2030
3.4 North America Posterior Pituitary for Injection Market Facts & Figures by Country
3.4.1 North America Posterior Pituitary for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Posterior Pituitary for Injection Sales by Country (2019-2030)
3.4.3 North America Posterior Pituitary for Injection Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Posterior Pituitary for Injection Market Facts & Figures by Country
3.5.1 Europe Posterior Pituitary for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Posterior Pituitary for Injection Sales by Country (2019-2030)
3.5.3 Europe Posterior Pituitary for Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Posterior Pituitary for Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Posterior Pituitary for Injection Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Posterior Pituitary for Injection Sales by Region (2019-2030)
3.6.3 Asia Pacific Posterior Pituitary for Injection Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Posterior Pituitary for Injection Market Facts & Figures by Country
3.7.1 Latin America Posterior Pituitary for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Posterior Pituitary for Injection Sales by Country (2019-2030)
3.7.3 Latin America Posterior Pituitary for Injection Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Posterior Pituitary for Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Posterior Pituitary for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Posterior Pituitary for Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Posterior Pituitary for Injection Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Posterior Pituitary for Injection Sales by Type (2019-2030)
4.1.1 Global Posterior Pituitary for Injection Sales by Type (2019-2024)
4.1.2 Global Posterior Pituitary for Injection Sales by Type (2025-2030)
4.1.3 Global Posterior Pituitary for Injection Sales Market Share by Type (2019-2030)
4.2 Global Posterior Pituitary for Injection Revenue by Type (2019-2030)
4.2.1 Global Posterior Pituitary for Injection Revenue by Type (2019-2024)
4.2.2 Global Posterior Pituitary for Injection Revenue by Type (2025-2030)
4.2.3 Global Posterior Pituitary for Injection Revenue Market Share by Type (2019-2030)
4.3 Global Posterior Pituitary for Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Posterior Pituitary for Injection Sales by Application (2019-2030)
5.1.1 Global Posterior Pituitary for Injection Sales by Application (2019-2024)
5.1.2 Global Posterior Pituitary for Injection Sales by Application (2025-2030)
5.1.3 Global Posterior Pituitary for Injection Sales Market Share by Application (2019-2030)
5.2 Global Posterior Pituitary for Injection Revenue by Application (2019-2030)
5.2.1 Global Posterior Pituitary for Injection Revenue by Application (2019-2024)
5.2.2 Global Posterior Pituitary for Injection Revenue by Application (2025-2030)
5.2.3 Global Posterior Pituitary for Injection Revenue Market Share by Application (2019-2030)
5.3 Global Posterior Pituitary for Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Eisai (Liaoning) Pharmaceutical
6.1.1 Eisai (Liaoning) Pharmaceutical Company Information
6.1.2 Eisai (Liaoning) Pharmaceutical Description and Business Overview
6.1.3 Eisai (Liaoning) Pharmaceutical Posterior Pituitary for Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Eisai (Liaoning) Pharmaceutical Posterior Pituitary for Injection Product Portfolio
6.1.5 Eisai (Liaoning) Pharmaceutical Recent Developments/Updates
6.2 Shanghai No. 1 Biochemical & Pharmaceutical
6.2.1 Shanghai No. 1 Biochemical & Pharmaceutical Company Information
6.2.2 Shanghai No. 1 Biochemical & Pharmaceutical Description and Business Overview
6.2.3 Shanghai No. 1 Biochemical & Pharmaceutical Posterior Pituitary for Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Shanghai No. 1 Biochemical & Pharmaceutical Posterior Pituitary for Injection Product Portfolio
6.2.5 Shanghai No. 1 Biochemical & Pharmaceutical Recent Developments/Updates
6.3 Nanjing Xinbai Pharmaceutical
6.3.1 Nanjing Xinbai Pharmaceutical Company Information
6.3.2 Nanjing Xinbai Pharmaceutical Description and Business Overview
6.3.3 Nanjing Xinbai Pharmaceutical Posterior Pituitary for Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Nanjing Xinbai Pharmaceutical Posterior Pituitary for Injection Product Portfolio
6.3.5 Nanjing Xinbai Pharmaceutical Recent Developments/Updates
6.4 Anhui Hongye Pharmaceutical
6.4.1 Anhui Hongye Pharmaceutical Company Information
6.4.2 Anhui Hongye Pharmaceutical Description and Business Overview
6.4.3 Anhui Hongye Pharmaceutical Posterior Pituitary for Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Anhui Hongye Pharmaceutical Posterior Pituitary for Injection Product Portfolio
6.4.5 Anhui Hongye Pharmaceutical Recent Developments/Updates
6.5 Kamp Pharmaceutical
6.5.1 Kamp Pharmaceutical Company Information
6.5.2 Kamp Pharmaceutical Description and Business Overview
6.5.3 Kamp Pharmaceutical Posterior Pituitary for Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Kamp Pharmaceutical Posterior Pituitary for Injection Product Portfolio
6.5.5 Kamp Pharmaceutical Recent Developments/Updates
6.6 Chengdu Hepatunn Pharmaceutical
6.6.1 Chengdu Hepatunn Pharmaceutical Company Information
6.6.2 Chengdu Hepatunn Pharmaceutical Description and Business Overview
6.6.3 Chengdu Hepatunn Pharmaceutical Posterior Pituitary for Injection Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Chengdu Hepatunn Pharmaceutical Posterior Pituitary for Injection Product Portfolio
6.6.5 Chengdu Hepatunn Pharmaceutical Recent Developments/Updates
6.7 Beijing Science Sun
6.7.1 Beijing Science Sun Company Information
6.7.2 Beijing Science Sun Description and Business Overview
6.7.3 Beijing Science Sun Posterior Pituitary for Injection Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Beijing Science Sun Posterior Pituitary for Injection Product Portfolio
6.7.5 Beijing Science Sun Recent Developments/Updates
6.8 Shanghai Harvest Pharmaceutical
6.8.1 Shanghai Harvest Pharmaceutical Company Information
6.8.2 Shanghai Harvest Pharmaceutical Description and Business Overview
6.8.3 Shanghai Harvest Pharmaceutical Posterior Pituitary for Injection Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Shanghai Harvest Pharmaceutical Posterior Pituitary for Injection Product Portfolio
6.8.5 Shanghai Harvest Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Posterior Pituitary for Injection Industry Chain Analysis
7.2 Posterior Pituitary for Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Posterior Pituitary for Injection Production Mode & Process
7.4 Posterior Pituitary for Injection Sales and Marketing
7.4.1 Posterior Pituitary for Injection Sales Channels
7.4.2 Posterior Pituitary for Injection Distributors
7.5 Posterior Pituitary for Injection Customers
8 Posterior Pituitary for Injection Market Dynamics
8.1 Posterior Pituitary for Injection Industry Trends
8.2 Posterior Pituitary for Injection Market Drivers
8.3 Posterior Pituitary for Injection Market Challenges
8.4 Posterior Pituitary for Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Posterior Pituitary for Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Posterior Pituitary for Injection Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Posterior Pituitary for Injection Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Posterior Pituitary for Injection Sales (K Dose) of Key Manufacturers (2019-2024)
 Table 5. Global Posterior Pituitary for Injection Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Posterior Pituitary for Injection Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Posterior Pituitary for Injection Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Posterior Pituitary for Injection Average Price (US$/Dose) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Posterior Pituitary for Injection, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Posterior Pituitary for Injection, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Posterior Pituitary for Injection, Product Type & Application
 Table 12. Global Key Manufacturers of Posterior Pituitary for Injection, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Posterior Pituitary for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Posterior Pituitary for Injection as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Posterior Pituitary for Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Posterior Pituitary for Injection Sales by Region (2019-2024) & (K Dose)
 Table 18. Global Posterior Pituitary for Injection Sales Market Share by Region (2019-2024)
 Table 19. Global Posterior Pituitary for Injection Sales by Region (2025-2030) & (K Dose)
 Table 20. Global Posterior Pituitary for Injection Sales Market Share by Region (2025-2030)
 Table 21. Global Posterior Pituitary for Injection Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Posterior Pituitary for Injection Revenue Market Share by Region (2019-2024)
 Table 23. Global Posterior Pituitary for Injection Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Posterior Pituitary for Injection Revenue Market Share by Region (2025-2030)
 Table 25. North America Posterior Pituitary for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Posterior Pituitary for Injection Sales by Country (2019-2024) & (K Dose)
 Table 27. North America Posterior Pituitary for Injection Sales by Country (2025-2030) & (K Dose)
 Table 28. North America Posterior Pituitary for Injection Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Posterior Pituitary for Injection Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Posterior Pituitary for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Posterior Pituitary for Injection Sales by Country (2019-2024) & (K Dose)
 Table 32. Europe Posterior Pituitary for Injection Sales by Country (2025-2030) & (K Dose)
 Table 33. Europe Posterior Pituitary for Injection Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Posterior Pituitary for Injection Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Posterior Pituitary for Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Posterior Pituitary for Injection Sales by Region (2019-2024) & (K Dose)
 Table 37. Asia Pacific Posterior Pituitary for Injection Sales by Region (2025-2030) & (K Dose)
 Table 38. Asia Pacific Posterior Pituitary for Injection Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Posterior Pituitary for Injection Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Posterior Pituitary for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Posterior Pituitary for Injection Sales by Country (2019-2024) & (K Dose)
 Table 42. Latin America Posterior Pituitary for Injection Sales by Country (2025-2030) & (K Dose)
 Table 43. Latin America Posterior Pituitary for Injection Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Posterior Pituitary for Injection Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Posterior Pituitary for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Posterior Pituitary for Injection Sales by Country (2019-2024) & (K Dose)
 Table 47. Middle East and Africa Posterior Pituitary for Injection Sales by Country (2025-2030) & (K Dose)
 Table 48. Middle East and Africa Posterior Pituitary for Injection Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Posterior Pituitary for Injection Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Posterior Pituitary for Injection Sales (K Dose) by Type (2019-2024)
 Table 51. Global Posterior Pituitary for Injection Sales (K Dose) by Type (2025-2030)
 Table 52. Global Posterior Pituitary for Injection Sales Market Share by Type (2019-2024)
 Table 53. Global Posterior Pituitary for Injection Sales Market Share by Type (2025-2030)
 Table 54. Global Posterior Pituitary for Injection Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Posterior Pituitary for Injection Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Posterior Pituitary for Injection Revenue Market Share by Type (2019-2024)
 Table 57. Global Posterior Pituitary for Injection Revenue Market Share by Type (2025-2030)
 Table 58. Global Posterior Pituitary for Injection Price (US$/Dose) by Type (2019-2024)
 Table 59. Global Posterior Pituitary for Injection Price (US$/Dose) by Type (2025-2030)
 Table 60. Global Posterior Pituitary for Injection Sales (K Dose) by Application (2019-2024)
 Table 61. Global Posterior Pituitary for Injection Sales (K Dose) by Application (2025-2030)
 Table 62. Global Posterior Pituitary for Injection Sales Market Share by Application (2019-2024)
 Table 63. Global Posterior Pituitary for Injection Sales Market Share by Application (2025-2030)
 Table 64. Global Posterior Pituitary for Injection Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Posterior Pituitary for Injection Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Posterior Pituitary for Injection Revenue Market Share by Application (2019-2024)
 Table 67. Global Posterior Pituitary for Injection Revenue Market Share by Application (2025-2030)
 Table 68. Global Posterior Pituitary for Injection Price (US$/Dose) by Application (2019-2024)
 Table 69. Global Posterior Pituitary for Injection Price (US$/Dose) by Application (2025-2030)
 Table 70. Eisai (Liaoning) Pharmaceutical Company Information
 Table 71. Eisai (Liaoning) Pharmaceutical Description and Business Overview
 Table 72. Eisai (Liaoning) Pharmaceutical Posterior Pituitary for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 73. Eisai (Liaoning) Pharmaceutical Posterior Pituitary for Injection Product
 Table 74. Eisai (Liaoning) Pharmaceutical Recent Developments/Updates
 Table 75. Shanghai No. 1 Biochemical & Pharmaceutical Company Information
 Table 76. Shanghai No. 1 Biochemical & Pharmaceutical Description and Business Overview
 Table 77. Shanghai No. 1 Biochemical & Pharmaceutical Posterior Pituitary for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 78. Shanghai No. 1 Biochemical & Pharmaceutical Posterior Pituitary for Injection Product
 Table 79. Shanghai No. 1 Biochemical & Pharmaceutical Recent Developments/Updates
 Table 80. Nanjing Xinbai Pharmaceutical Company Information
 Table 81. Nanjing Xinbai Pharmaceutical Description and Business Overview
 Table 82. Nanjing Xinbai Pharmaceutical Posterior Pituitary for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 83. Nanjing Xinbai Pharmaceutical Posterior Pituitary for Injection Product
 Table 84. Nanjing Xinbai Pharmaceutical Recent Developments/Updates
 Table 85. Anhui Hongye Pharmaceutical Company Information
 Table 86. Anhui Hongye Pharmaceutical Description and Business Overview
 Table 87. Anhui Hongye Pharmaceutical Posterior Pituitary for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 88. Anhui Hongye Pharmaceutical Posterior Pituitary for Injection Product
 Table 89. Anhui Hongye Pharmaceutical Recent Developments/Updates
 Table 90. Kamp Pharmaceutical Company Information
 Table 91. Kamp Pharmaceutical Description and Business Overview
 Table 92. Kamp Pharmaceutical Posterior Pituitary for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 93. Kamp Pharmaceutical Posterior Pituitary for Injection Product
 Table 94. Kamp Pharmaceutical Recent Developments/Updates
 Table 95. Chengdu Hepatunn Pharmaceutical Company Information
 Table 96. Chengdu Hepatunn Pharmaceutical Description and Business Overview
 Table 97. Chengdu Hepatunn Pharmaceutical Posterior Pituitary for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 98. Chengdu Hepatunn Pharmaceutical Posterior Pituitary for Injection Product
 Table 99. Chengdu Hepatunn Pharmaceutical Recent Developments/Updates
 Table 100. Beijing Science Sun Company Information
 Table 101. Beijing Science Sun Description and Business Overview
 Table 102. Beijing Science Sun Posterior Pituitary for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 103. Beijing Science Sun Posterior Pituitary for Injection Product
 Table 104. Beijing Science Sun Recent Developments/Updates
 Table 105. Shanghai Harvest Pharmaceutical Company Information
 Table 106. Shanghai Harvest Pharmaceutical Description and Business Overview
 Table 107. Shanghai Harvest Pharmaceutical Posterior Pituitary for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 108. Shanghai Harvest Pharmaceutical Posterior Pituitary for Injection Product
 Table 109. Shanghai Harvest Pharmaceutical Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Posterior Pituitary for Injection Distributors List
 Table 113. Posterior Pituitary for Injection Customers List
 Table 114. Posterior Pituitary for Injection Market Trends
 Table 115. Posterior Pituitary for Injection Market Drivers
 Table 116. Posterior Pituitary for Injection Market Challenges
 Table 117. Posterior Pituitary for Injection Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Posterior Pituitary for Injection
 Figure 2. Global Posterior Pituitary for Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Posterior Pituitary for Injection Market Share by Type: 2023 & 2030
 Figure 4. Intramuscular Injection Product Picture
 Figure 5. Intravenous Drip Product Picture
 Figure 6. Global Posterior Pituitary for Injection Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global Posterior Pituitary for Injection Market Share by Application: 2023 & 2030
 Figure 8. Lung or Bronchi Bleeding
 Figure 9. Gastrointestinal Bleeding
 Figure 10. Obstetric Oxytocia
 Figure 11. Others
 Figure 12. Global Posterior Pituitary for Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 13. Global Posterior Pituitary for Injection Market Size (2019-2030) & (US$ Million)
 Figure 14. Global Posterior Pituitary for Injection Sales (2019-2030) & (K Dose)
 Figure 15. Global Posterior Pituitary for Injection Average Price (US$/Dose) & (2019-2030)
 Figure 16. Posterior Pituitary for Injection Report Years Considered
 Figure 17. Posterior Pituitary for Injection Sales Share by Manufacturers in 2023
 Figure 18. Global Posterior Pituitary for Injection Revenue Share by Manufacturers in 2023
 Figure 19. Global 5 and 10 Largest Posterior Pituitary for Injection Players: Market Share by Revenue in Posterior Pituitary for Injection in 2023
 Figure 20. Posterior Pituitary for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 21. Global Posterior Pituitary for Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 22. North America Posterior Pituitary for Injection Sales Market Share by Country (2019-2030)
 Figure 23. North America Posterior Pituitary for Injection Revenue Market Share by Country (2019-2030)
 Figure 24. United States Posterior Pituitary for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Canada Posterior Pituitary for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Europe Posterior Pituitary for Injection Sales Market Share by Country (2019-2030)
 Figure 27. Europe Posterior Pituitary for Injection Revenue Market Share by Country (2019-2030)
 Figure 28. Germany Posterior Pituitary for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. France Posterior Pituitary for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. U.K. Posterior Pituitary for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Italy Posterior Pituitary for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Russia Posterior Pituitary for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Asia Pacific Posterior Pituitary for Injection Sales Market Share by Region (2019-2030)
 Figure 34. Asia Pacific Posterior Pituitary for Injection Revenue Market Share by Region (2019-2030)
 Figure 35. China Posterior Pituitary for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. Japan Posterior Pituitary for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. South Korea Posterior Pituitary for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. India Posterior Pituitary for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Australia Posterior Pituitary for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. China Taiwan Posterior Pituitary for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Southeast Asia Posterior Pituitary for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Latin America Posterior Pituitary for Injection Sales Market Share by Country (2019-2030)
 Figure 43. Mexico Posterior Pituitary for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Brazil Posterior Pituitary for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Argentina Posterior Pituitary for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Colombia Posterior Pituitary for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Middle East and Africa Posterior Pituitary for Injection Sales Market Share by Country (2019-2030)
 Figure 48. Middle East and Africa Posterior Pituitary for Injection Revenue Market Share by Country (2019-2030)
 Figure 49. Turkey Posterior Pituitary for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Saudi Arabia Posterior Pituitary for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. UAE Posterior Pituitary for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Global Sales Market Share of Posterior Pituitary for Injection by Type (2019-2030)
 Figure 53. Global Revenue Market Share of Posterior Pituitary for Injection by Type (2019-2030)
 Figure 54. Global Posterior Pituitary for Injection Price (US$/Dose) by Type (2019-2030)
 Figure 55. Global Sales Market Share of Posterior Pituitary for Injection by Application (2019-2030)
 Figure 56. Global Revenue Market Share of Posterior Pituitary for Injection by Application (2019-2030)
 Figure 57. Global Posterior Pituitary for Injection Price (US$/Dose) by Application (2019-2030)
 Figure 58. Posterior Pituitary for Injection Value Chain
 Figure 59. Posterior Pituitary for Injection Production Process
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network